Redeye: Circio H1 2024 - Collaborations now active
Redeye revises its update on Circio after the H1 report. The company is making progress with CircVec, but funding is problematic considering the low market capitalisation and need to obtain funding from convertible bonds.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/